Black Rock Inc. Electro Core, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.21 - $5.63 $155 - $4,166	-740 Reduced 1.98%	36,665 $9,000
Q3 2022 Nov 14, 2022	SELL	$0.46 - $6.75 $528 - $7,749	-1,148 Reduced 2.98%	37,405 $15,000
Q2 2022 Aug 12, 2022	SELL	$0.27 - $0.61 $38,426 - $86,815	-142,320 Reduced 78.69%	38,553 $19,000
Q1 2022 May 12, 2022	SELL	$0.5 - $0.88 $3,816 - $6,716	-7,632 Reduced 4.05%	180,873 $105,000
Q4 2021 Feb 10, 2022	BUY	$0.58 - $1.09 $12,824 - $24,102	22,112 Added 13.29%	188,505 $109,000
Q3 2021 Nov 09, 2021	BUY	$0.93 - $1.18 $31,060 - $39,409	33,398 Added 25.11%	166,393 $188,000
Q2 2021 Aug 11, 2021	BUY	$1.19 - $2.06 $158,264 - $273,969	132,995 New	132,995 $158,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.09B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.